European Solar Photovoltaic Patent Revoked

In an oral decision issued today, the European Patent Office (EPO) revoked European Patent No. EP 0 871 979 issued to the University of Neuchatel (the Neuchatel patent), which pertains to solar photovoltaic (PV) technology. The Neuchatel patent is the subject of a lawsuit filed in Germany by OC Oerlikon Balzers AG, Liechtenstein alleging patent infringement against an Applied Materials thin film solar customer.

Following oral proceedings held on March 31 in Berlin, Germany, the EPO panel ruled that the Neuchatel patent is invalid in its entirety and accordingly revoked the patent. The University of Neuchatel may appeal this decision to an EPO Board of Appeal.

Applied Materials’ product offering for manufacturing thin film solar PV modules – the Applied SunFab™ line – is a fully integrated production line that delivers leading-edge manufacturing capability using advanced engineering, process equipment, diagnostics, automation and emissions abatement systems. Adapted from production-proven processes including Applied’s market-leading PECVD system, the SunFab line is the only production line for manufacturing ultra-large 5.7 m2 thin film solar PV modules. Each line can be configured with single or tandem junction technology and is optimized to lower customers’ manufacturing costs.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Applied Materials Inc. (2019, February 10). European Solar Photovoltaic Patent Revoked. AZoM. Retrieved on April 16, 2024 from https://www.azom.com/news.aspx?newsID=16264.

  • MLA

    Applied Materials Inc. "European Solar Photovoltaic Patent Revoked". AZoM. 16 April 2024. <https://www.azom.com/news.aspx?newsID=16264>.

  • Chicago

    Applied Materials Inc. "European Solar Photovoltaic Patent Revoked". AZoM. https://www.azom.com/news.aspx?newsID=16264. (accessed April 16, 2024).

  • Harvard

    Applied Materials Inc. 2019. European Solar Photovoltaic Patent Revoked. AZoM, viewed 16 April 2024, https://www.azom.com/news.aspx?newsID=16264.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.